| [1] |
吴晨曦.慢性丙肝患者血清谷丙转氨酶水平、丙肝病毒RNA定量对干扰素疗效的影响分析.中外医疗,2013,34:56-57.
|
| [2] |
丁柳,钟慧钰,宋兴勃,等.四川人群丙肝病毒基因型分布及与抗病毒疗效的相关性.四川大学学报(医学版).2015,4:573-577.
|
| [3] |
罗旗,伍春霞,李成敏,等.白细胞介素28B基因多态性以及表达水平对慢性丙型肝炎患者抗病毒治疗效果的影响研究.重庆医科大学学报.2015,3:335-339.
|
| [4] |
中华医学会肝病学分会、中华医学会传染病与寄生虫病学分会.丙型肝炎防治指南.中华实验和临床感染病杂志(电子版).2015,5:590-607.
|
| [5] |
梅蕾,祝卫东,朱跃红,等.聚乙二醇干扰素α-2a联合利巴韦林治疗基因1b型慢性丙型肝炎临床观察.肝脏.2014,12:952-954.
|
| [6] |
吴芳,孙凤霞,徐春军. γ-谷氨酰转肽酶在肝脏疾病诊断和预后中的意义.中华实验和临床感染病杂志(电子版).2015,5:616-620.
|
| [7] |
Weich V, Herrmann E, Chung TL, et al. The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection. Gastroenterol. 2011, 12:1427-1436.
|
| [8] |
Coban S, Idilman R, Erden E, et al. Gamma-glutamyltran-speptidase in predicting sustained virological response in individuals with chronic?hepatitis C. Hepatogastroenterology, 2011, 109: 1301-1306.
|
| [9] |
Everhart JE, Wright EC. Association of γ-glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV). Hepatology 2013, 5: 1725-1733.
|
| [10] |
孙万里,石铭,王楠,等.ALT、GGT 及IL28B基因多态性与PEG干扰素联合利巴韦林治疗HCV基因型1患者早期应答的相关性.中国保健营养.2013,8:152-153.
|
